×
News Home

Does Petros Pharmaceuticals Inc (PTPI) Have What it Takes to be in Your Portfolio Wednesday?

Wednesday, October 27, 2021 02:17 PM | InvestorsObserver Analysts
Does Petros Pharmaceuticals Inc (PTPI) Have What it Takes to be in Your Portfolio Wednesday?

A rating of 25 puts Petros Pharmaceuticals Inc (PTPI) near the bottom of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Petros Pharmaceuticals Inc's score of 25 means it scores higher than 25% of stocks in the industry. Petros Pharmaceuticals Inc also received an overall rating of 13, putting it above 13% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 141 out of the 148 industries.

Overall Score - 13
PTPI has an Overall Score of 13. Find out what this means to you and get the rest of the rankings on PTPI!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Petros Pharmaceuticals Inc Stock Today?

Petros Pharmaceuticals Inc (PTPI) stock is down -4.19% while the S&P 500 is up 0.2% as of 2:13 PM on Wednesday, Oct 27. PTPI is lower by -$0.08 from the previous closing price of $1.91 on volume of 176,607 shares. Over the past year the S&P 500 is up 24.94% while PTPI is lower by -54.14%. PTPI lost -$0.81 per share the over the last 12 months. Click Here to get the full Stock Report for Petros Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App